1Bercovitch M, Adunsky A. Patients of high-dose morphine use in a home-care hospice service[J]. Cancer, 2004, 101 (6) : 1437 - 1477.
2Skaer TL. Transdermal opioids for cancer pain [ J ]. Health Qual Life Outcomes, 2006, 4:24.
3Kim JH, Kim M, Sung CW, et al. High-dose fentanyl patch for cancer pain of a patient with cholangiocarcinoma [ J ]. Korean ] Intern Med, 2010,25 ( 3 ) :337 - 340.
5Shinjo T, Okada M. The opioid combination of transdermal fenta- nyl and sustained release morphine for refractory cancer pain a case report[ J]. Gan To Kagaku Ryoho, 2005,32 ( 12 ) : 1997 - 2000.
二级参考文献7
1Bercovitch M,Adunsky A. Patterns of High-Dose Morphine Use in a Home-Care Hospice Service [ J ]. Cancer, 2004, 101 ( 6 ) : 1473 - 1477.
2Indelicato RA, Portenoy RK. Opioid Rotation in the Management of Refractory Cancer Pain[ J]. J Clin Oncol,2002,20 ( 1 ) :348 - 352.
3Skaer TL. Transdermal opioids for cancer pain [ J ]. Health Qual Life Outcomes, 2006,4:24.
4Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium[ J]. Drugs, 2001,61 (7) :955 - 977.
5Vigano A, Bruera E, Suarez-Almazor ME. Age, pain intensity and opioid dose in patients with advanced cancer[J]. Cancer, 1998, 83(6) :1244 - 1250.
6Quigley C. Opioid switching to improve pain relief and drug tolerability[J]. Cochrane Database Syst Rev, 2004(3) :CD004847.
7Shinjo T, Okada M. The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain a case report [ J ]. Gan To Kagaku Ryoho, 2005,32 (12) : 1997 - 2000.
